I think the potential of Agenic is to rethink how work gets done overall.

It challenges all sorts of traditional orthodoxies around how organizations execute the work at hand.

That's Jason Gersatus, CEO of Deloitte U.S., talking about the transformational potential of A.Gentic AI.

Join him later to learn why agents are a game changer for businesses across industries.

Here's your closing bell brief for Monday, April 20th. I'm Pierre Bienname for the Wall Street Journal.

The latest tensions between the U.S. and Iran have unwound some of the optimism that swept through markets last week.

American negotiators are expected to arrive in Pakistan for talks with Iran this week, though Tehran has cast doubt on its participation.

Stocks slipped with the S&P 500 down 0.2 percent and the Dow industrials roughly flat.

The NASDAQ composite was down 0.3%, breaking a 13-session winning streak, its longest since 1992.

Brent Crude Futures rose 5.6% to around $95.48 a barrel.

The move was relatively small compared with the wild swings seen earlier during the war.

Among individual companies, AST Space Mobile shares tumbled more than 5%.

A satellite that Jeff Bezos's blue origin was carrying for the company

was incorrectly deployed yesterday and ended up in the wrong location in space.

Marvell technology shares jumped nearly 6%.

The chipmaker is in talks with Google to build new

artificial intelligence chips with inference. The workplace software company at Lassian's shares rose

nearly 7%. The company led the NASDAQ 100 at midday, bouncing back after recent worries about

competition from new artificial intelligence tools.

And Eli Lilly's shares fell three quarters of a percent.

The drugmaker struck a deal to acquire Colonia Therapeutics for $3.25 billion, the companies said today.

Colonia, which is privately held, is developing a next generation treatment for the blood cancer

...